SYSNAV Healthcare announces that the European Medicines Agency (EMA) considers that for ambulant Duchenne Muscular Dystrophy…
Month: August 2023
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has…
Mirati Therapeutics Announces Pricing of Upsized Public Offering
Mirati Therapeutics, Inc. (Nasdaq: MRTX), a commercial stage biotechnology company, today announced the pricing of an underwritten…
Global Clear Aligners Market Analysis Report 2023: Addressing Malocclusions – Clear Aligners Emerge as a Preferred Treatment Choice
The “Clear Aligners Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Age,…
Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities
Mindray, a leading global provider of medical devices and solutions and Operation Smile, a global nonprofit dedicated to…
BioXcel Therapeutics, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action…
Dental Implants Market to grow at a CAGR of 6.7% from 2022 to 2027; An increasing number of product launches will drive market growth -Technavio
The dental implant market is estimated to grow at a CAGR of 6.7% between 2022 and 2027. The market size is…
Global Industrial Gases Industry Report 2023-2028: Booming Healthcare and Food Processing Industries and Growing Investments in New Applications Fuels Market Expansion
The “Industrial Gases Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type,…
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax’s “PANDA” Approach
EpiVax Inc. announces the publication of results from a research collaboration with the Food and Drug…
Zumutor Biologics Inc announces FDA clearance of IND application of ZM008, a novel monoclonal antibody drug against multiple solid cancers
Zumutor Biologics Inc “Zumutor”, a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today…